Neogen (NEOG) Change in Acquisitions & Divestments (2010 - 2025)
Neogen's (NEOG) quarterly Change in Acquisitions & Divestments came in at $25000.0 in Q2 2025, down 99.63% year-on-year from $6.7 million in Q2 2024, and up 200.0% quarter-over-quarter from -$25000.0 in Q1 2025.
Neogen (NEOG) Change in Acquisitions & Divestments (2010 - 2025) Analysis & Trends
Neogen's Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $25000.0 for Q2 2025.
- On a quarterly basis, Change in Acquisitions & Divestments fell 99.63% year-over-year to $25000.0 in Q2 2025; TTM through Feb 2026 was $25000.0, a 99.64% decrease from a year earlier, with the FY2025 full-year figure at $325000.0, down 99.6% from the prior year.
- Change in Acquisitions & Divestments advanced to $25000.0 in Q2 2025 per NEOG's latest filing, from -$25000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $293.2 million in Q1 2021 and bottomed at -$25000.0 in Q1 2025.
- The 5-year median for Change in Acquisitions & Divestments is $60.3 million (2023), against an average of $69.8 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 191.05% in 2021 and slumped 100.14% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $85.3 million in 2021, then retreated by 24.65% to $64.3 million in 2022, then sank by 44.11% to $35.9 million in 2023, then slumped by 99.1% to $325000.0 in 2024, then tumbled by 92.31% to $25000.0 in 2025.
- Per Business Quant, the three latest NEOG Change in Acquisitions & Divestments figures stand at $25000.0 (Q2 2025), -$25000.0 (Q1 2025), and $325000.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | Neogen | 2.05 Bn | 1.89 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 25,000.00 |
| May 31, 2025 | 25,000.00 |
| Feb 28, 2025 | -25,000.00 |
| Feb 28, 2025 | -25,000.00 |
| Aug 31, 2024 | 325,000.00 |
| Aug 31, 2024 | 325,000.00 |
| May 31, 2024 | 6.69 Mn |
| May 31, 2024 | 6.69 Mn |
| Feb 29, 2024 | 17.49 Mn |
| Feb 29, 2024 | 17.49 Mn |
| Nov 30, 2023 | 35.92 Mn |
| Nov 30, 2023 | 35.92 Mn |
| Aug 31, 2023 | 21.91 Mn |
| Aug 31, 2023 | 21.91 Mn |
| May 31, 2023 | 33.75 Mn |
| May 31, 2023 | 33.75 Mn |
| Feb 28, 2023 | 60.26 Mn |
| Feb 28, 2023 | 60.26 Mn |
| Nov 30, 2022 | 64.28 Mn |
| Nov 30, 2022 | 64.28 Mn |